VL
INDV icon

Vima LLC’s Indivior Pharmaceuticals INDV Stock Holding History

Vima LLC’s Portfolio INDV Stock Details INDV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$24.7K Buy
+603
New +$21.9K 0.02% 204
2024
Q1 		– Sell
-50
Closed -$764 – 473
2023
Q4 		$764 Buy
+50
New +$888 ﹤0.01% 362

Other funds holding INDV

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
OCM
Oaktree Capital Management Los Angeles, California $7.21B AUM 45.97% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Fuller & Thaler Asset Management
Fuller & Thaler Asset Management San Mateo, California $36.7B AUM 74.15% 1-Year Est. Return
TSC
Two Seas Capital Rye, New York $5.05B AUM 164.99% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Vima LLC's INDV Position: Q2 2026 in Review

Vima LLC opened a new position in Indivior Pharmaceuticals (INDV) in Q2 2026: 603 shares worth $24.7K. The stake represents 0.02% of the portfolio and ranks #204 among its holdings. This is a return to the name: Vima LLC previously reported a position in INDV as recently as Q4 2023.

Vima LLC first reported a position in INDV in Q4 2023 and has held it in 2 quarters since. 338 funds tracked by Wall St. Rank hold INDV as of Q2 2026.

  • Vima LLC held 603 shares of Indivior Pharmaceuticals worth $24.7K as of Q2 2026.
  • Indivior Pharmaceuticals was a new Vima LLC position in Q2 2026.
  • Indivior Pharmaceuticals made up 0.02% of Vima LLC's portfolio in Q2 2026, its #204 holding.
  • Vima LLC first reported a position in Indivior Pharmaceuticals in Q4 2023 and has held it in 2 quarters since.
  • 338 funds tracked by Wall St. Rank held Indivior Pharmaceuticals as of Q2 2026.

Based on Vima LLC's 13F filing for Q2 2026, filed 24 Jul 2026.